Acorda (ACOR) fell after its Phase 3 study caused 5 deaths. $ACOR, Acorda Therapeutics, Inc. / H1 Rish: HighCatalyst: NegativeAcorda Therapeutics (ACOR) Will not Recover. Agree or disagree?Login now. Free. Vote.